Tyson Timothy
- SEC CIK
- 0001207405
No open-market purchases or sales filed in the past year.
Current role at each company
- SYRS Syros Pharmaceuticals, Inc.Directoras of Jun 7, 2024
- TYME Tyme Technologies, Inc.Directoras of Sep 16, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Tyson Timothy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SYRS Syros Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2022 (view filing) | Sep 29-30 | 4 days | Tyson TimothyDirector | PPurchase | +16.9K | $6.26 | +$106.0K | +211.6%24.9K after | 2 lots |